Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 49 to 59 of 59 entries
Sorted by: Best Match Show Resources per page
Global DNA methylation in suicidal ideation and suicide attempt in schizophrenia.

Psychiatric genetics

Bani-Fatemi A, Raymond R, Adanty C, Dai N, Gerretsen P, Graff A, Nobrega JN, De Luca V.
PMID: 33399315
Psychiatr Genet. 2021 Apr 01;31(2):65-71. doi: 10.1097/YPG.0000000000000273.

Suicidal behavior is influenced by many risk factors such as childhood trauma, stressful life events, genetic factors, and severe mental illnesses. Suicidal ideation is present in 50% of schizophrenia patients and is associated with an elevated risk of suicide...

Cite
Bani-Fatemi A, Raymond R, Adanty C, et al. Global DNA methylation in suicidal ideation and suicide attempt in schizophrenia. Psychiatr Genet. 2021;31(2):65-71doi: 10.1097/YPG.0000000000000273.
Bani-Fatemi, A., Raymond, R., Adanty, C., Dai, N., Gerretsen, P., Graff, A., Nobrega, J. N., & De Luca, V. (2021). Global DNA methylation in suicidal ideation and suicide attempt in schizophrenia. Psychiatric genetics, 31(2), 65-71. https://doi.org/10.1097/YPG.0000000000000273
Bani-Fatemi, Ali, et al. "Global DNA methylation in suicidal ideation and suicide attempt in schizophrenia." Psychiatric genetics vol. 31,2 (2021): 65-71. doi: https://doi.org/10.1097/YPG.0000000000000273
Bani-Fatemi A, Raymond R, Adanty C, Dai N, Gerretsen P, Graff A, Nobrega JN, De Luca V. Global DNA methylation in suicidal ideation and suicide attempt in schizophrenia. Psychiatr Genet. 2021 Apr 01;31(2):65-71. doi: 10.1097/YPG.0000000000000273. PMID: 33399315.
Copy Download .nbib Format: NLM
Effects of CYP2C19*17 genetic polymorphisms on plasma and saliva concentrations of diazepam in patients with alcohol withdrawal syndrome.

Psychiatric genetics

Skryabin VY, Zastrozhin M, Torrado M, Grishina E, Ryzhikova K, Shipitsyn V, Galaktionova T, Bryun E, Sychev D.
PMID: 35001019
Psychiatr Genet. 2022 Jan 06; doi: 10.1097/YPG.0000000000000306. Epub 2022 Jan 06.

INTRODUCTION: Diazepam is one of the most commonly prescribed tranquilizers for the therapy of alcohol withdrawal syndrome (AWS). However, diazepam therapy often turns out to be ineffective, and some patients experience dose-dependent adverse drug reactions. Previous studies have shown...

Cite
Skryabin VY, Zastrozhin M, Torrado M, et al. Effects of CYP2C19*17 genetic polymorphisms on plasma and saliva concentrations of diazepam in patients with alcohol withdrawal syndrome. Psychiatr Genet. 2022;doi: 10.1097/YPG.0000000000000306.
Skryabin, V. Y., Zastrozhin, M., Torrado, M., Grishina, E., Ryzhikova, K., Shipitsyn, V., Galaktionova, T., Bryun, E., & Sychev, D. (2022). Effects of CYP2C19*17 genetic polymorphisms on plasma and saliva concentrations of diazepam in patients with alcohol withdrawal syndrome. Psychiatric genetics, . https://doi.org/10.1097/YPG.0000000000000306
Skryabin, Valentin Yurievich, et al. "Effects of CYP2C19*17 genetic polymorphisms on plasma and saliva concentrations of diazepam in patients with alcohol withdrawal syndrome." Psychiatric genetics vol. (2022). doi: https://doi.org/10.1097/YPG.0000000000000306
Skryabin VY, Zastrozhin M, Torrado M, Grishina E, Ryzhikova K, Shipitsyn V, Galaktionova T, Bryun E, Sychev D. Effects of CYP2C19*17 genetic polymorphisms on plasma and saliva concentrations of diazepam in patients with alcohol withdrawal syndrome. Psychiatr Genet. 2022 Jan 06; doi: 10.1097/YPG.0000000000000306. Epub 2022 Jan 06. PMID: 35001019.
Copy Download .nbib Format: NLM
The functional polymorphisms linked with interleukin-1β gene expression are associated with bipolar disorder.

Psychiatric genetics

Pu X, Li J, Ma X, Yang S, Wang L.
PMID: 33707400
Psychiatr Genet. 2021 Apr 01;31(2):72-78. doi: 10.1097/YPG.0000000000000272.

BACKGROUND: Bipolar disorder (BD) is a severe psychiatric illness attributable to multifactorial risk components (e.g. environmental stimuli, neuroinflammation, etc.), and genetic variations affecting these risk components are considered pivotal predisposing factors. The interleukin-1β (IL-1β) gene and its protein product...

Cite
Pu X, Li J, Ma X, et al. The functional polymorphisms linked with interleukin-1β gene expression are associated with bipolar disorder. Psychiatr Genet. 2021;31(2):72-78doi: 10.1097/YPG.0000000000000272.
Pu, X., Li, J., Ma, X., Yang, S., & Wang, L. (2021). The functional polymorphisms linked with interleukin-1β gene expression are associated with bipolar disorder. Psychiatric genetics, 31(2), 72-78. https://doi.org/10.1097/YPG.0000000000000272
Pu, Xingfu, et al. "The functional polymorphisms linked with interleukin-1β gene expression are associated with bipolar disorder." Psychiatric genetics vol. 31,2 (2021): 72-78. doi: https://doi.org/10.1097/YPG.0000000000000272
Pu X, Li J, Ma X, Yang S, Wang L. The functional polymorphisms linked with interleukin-1β gene expression are associated with bipolar disorder. Psychiatr Genet. 2021 Apr 01;31(2):72-78. doi: 10.1097/YPG.0000000000000272. PMID: 33707400.
Copy Download .nbib Format: NLM
Metformin, valproic acid, and starvation induce seizures in a patient with partial SLC13A5 deficiency: A case of pharmaco-synergistic heterozygosity: Erratum.

Psychiatric genetics

[No authors listed]
PMID: 34230443
Psychiatr Genet. 2021 Aug 01;31(4):143. doi: 10.1097/YPG.0000000000000290.

No abstract available.

Cite
Metformin, valproic acid, and starvation induce seizures in a patient with partial SLC13A5 deficiency: A case of pharmaco-synergistic heterozygosity: Erratum. Psychiatr Genet. 2021;31(4):143doi: 10.1097/YPG.0000000000000290.
(2021). Metformin, valproic acid, and starvation induce seizures in a patient with partial SLC13A5 deficiency: A case of pharmaco-synergistic heterozygosity: Erratum. Psychiatric genetics, 31(4), 143. https://doi.org/10.1097/YPG.0000000000000290
"Metformin, valproic acid, and starvation induce seizures in a patient with partial SLC13A5 deficiency: A case of pharmaco-synergistic heterozygosity: Erratum." Psychiatric genetics vol. 31,4 (2021): 143. doi: https://doi.org/10.1097/YPG.0000000000000290
Metformin, valproic acid, and starvation induce seizures in a patient with partial SLC13A5 deficiency: A case of pharmaco-synergistic heterozygosity: Erratum. Psychiatr Genet. 2021 Aug 01;31(4):143. doi: 10.1097/YPG.0000000000000290. PMID: 34230443.
Copy Download .nbib Format: NLM
Psychiatric symptoms in an adolescent reveal a novel compound heterozygous mutation of the PANK2 gene in the atypical PKAN syndrome.

Psychiatric genetics

González Huerta LM, Gómez González S, Toral López J.
PMID: 33853092
Psychiatr Genet. 2021 Jun 01;31(3):95-99. doi: 10.1097/YPG.0000000000000278.

The proband in this study was a 16-year-old Mexican girl with psychotic and dyskinetic symptoms, and brain MRI showed at the basal ganglia the 'eye-of-the-tiger' sign. DNA direct sequencing identified a novel compound heterozygous mutation in the PANK2 gene....

Cite
González Huerta LM, Gómez González S, Toral López J. Psychiatric symptoms in an adolescent reveal a novel compound heterozygous mutation of the PANK2 gene in the atypical PKAN syndrome. Psychiatr Genet. 2021;31(3):95-99doi: 10.1097/YPG.0000000000000278.
González Huerta, L. M., Gómez González, S., & Toral López, J. (2021). Psychiatric symptoms in an adolescent reveal a novel compound heterozygous mutation of the PANK2 gene in the atypical PKAN syndrome. Psychiatric genetics, 31(3), 95-99. https://doi.org/10.1097/YPG.0000000000000278
González Huerta, Luz María, et al. "Psychiatric symptoms in an adolescent reveal a novel compound heterozygous mutation of the PANK2 gene in the atypical PKAN syndrome." Psychiatric genetics vol. 31,3 (2021): 95-99. doi: https://doi.org/10.1097/YPG.0000000000000278
González Huerta LM, Gómez González S, Toral López J. Psychiatric symptoms in an adolescent reveal a novel compound heterozygous mutation of the PANK2 gene in the atypical PKAN syndrome. Psychiatr Genet. 2021 Jun 01;31(3):95-99. doi: 10.1097/YPG.0000000000000278. PMID: 33853092.
Copy Download .nbib Format: NLM
Alexithymia is associated with reduced vitamin D levels, but not polymorphisms of the vitamin D binding-protein gene.

Psychiatric genetics

Terock J, Hannemann A, Weihs A, Janowitz D, Grabe HJ.
PMID: 34074948
Psychiatr Genet. 2021 Aug 01;31(4):126-134. doi: 10.1097/YPG.0000000000000283.

OBJECTIVE: Alexithymia is a personality trait characterized by difficulties in identifying and describing emotions, which is associated with various psychiatric disorders, including depression and posttraumatic stress disorder (PTSD). Its pathogenesis is incompletely understood but previous studies suggested that genetic...

Cite
Terock J, Hannemann A, Weihs A, et al. Alexithymia is associated with reduced vitamin D levels, but not polymorphisms of the vitamin D binding-protein gene. Psychiatr Genet. 2021;31(4):126-134doi: 10.1097/YPG.0000000000000283.
Terock, J., Hannemann, A., Weihs, A., Janowitz, D., & Grabe, H. J. (2021). Alexithymia is associated with reduced vitamin D levels, but not polymorphisms of the vitamin D binding-protein gene. Psychiatric genetics, 31(4), 126-134. https://doi.org/10.1097/YPG.0000000000000283
Terock, Jan, et al. "Alexithymia is associated with reduced vitamin D levels, but not polymorphisms of the vitamin D binding-protein gene." Psychiatric genetics vol. 31,4 (2021): 126-134. doi: https://doi.org/10.1097/YPG.0000000000000283
Terock J, Hannemann A, Weihs A, Janowitz D, Grabe HJ. Alexithymia is associated with reduced vitamin D levels, but not polymorphisms of the vitamin D binding-protein gene. Psychiatr Genet. 2021 Aug 01;31(4):126-134. doi: 10.1097/YPG.0000000000000283. PMID: 34074948.
Copy Download .nbib Format: NLM
Evaluation of hsa-let-7d-5p, hsa-let-7g-5p and hsa-miR-15b-5p plasma levels in patients with Alzheimer's disease.

Psychiatric genetics

Poursaei E, Abolghasemi M, Bornehdeli S, Shanehbandi D, Asadi M, Sadeghzadeh M, Rahmanpour D, Sadeh RN.
PMID: 34955516
Psychiatr Genet. 2021 Dec 23; doi: 10.1097/YPG.0000000000000303. Epub 2021 Dec 23.

BACKGROUND: Alzheimer's disease (AD) is a progressive neurodegenerative disorder MicroRNAs (miRNAs) may be promising diagnostic biomarkers for AD. Previous evidence shows that miR-15b-5p, hsa-let7g-5p and hsa-let7d-5p might confer potential blood biomarkers for timely diagnosis of AD. Therefore, in this...

Cite
Poursaei E, Abolghasemi M, Bornehdeli S, et al. Evaluation of hsa-let-7d-5p, hsa-let-7g-5p and hsa-miR-15b-5p plasma levels in patients with Alzheimer's disease. Psychiatr Genet. 2021;doi: 10.1097/YPG.0000000000000303.
Poursaei, E., Abolghasemi, M., Bornehdeli, S., Shanehbandi, D., Asadi, M., Sadeghzadeh, M., Rahmanpour, D., & Sadeh, R. N. (2021). Evaluation of hsa-let-7d-5p, hsa-let-7g-5p and hsa-miR-15b-5p plasma levels in patients with Alzheimer's disease. Psychiatric genetics, . https://doi.org/10.1097/YPG.0000000000000303
Poursaei, Elham, et al. "Evaluation of hsa-let-7d-5p, hsa-let-7g-5p and hsa-miR-15b-5p plasma levels in patients with Alzheimer's disease." Psychiatric genetics vol. (2021). doi: https://doi.org/10.1097/YPG.0000000000000303
Poursaei E, Abolghasemi M, Bornehdeli S, Shanehbandi D, Asadi M, Sadeghzadeh M, Rahmanpour D, Sadeh RN. Evaluation of hsa-let-7d-5p, hsa-let-7g-5p and hsa-miR-15b-5p plasma levels in patients with Alzheimer's disease. Psychiatr Genet. 2021 Dec 23; doi: 10.1097/YPG.0000000000000303. Epub 2021 Dec 23. PMID: 34955516.
Copy Download .nbib Format: NLM
Psychosis symptoms associated with Niemann-Pick disease type C.

Psychiatric genetics

Ong LT.
PMID: 34133410
Psychiatr Genet. 2021 Aug 01;31(4):107-118. doi: 10.1097/YPG.0000000000000286.

Niemann-Pick disease type C (NP-C) is a severe neurovisceral lipid storage disease that results in the accumulation of unesterified cholesterol in lysosomes or endosomes. The clinical presentations of NP-C are variable which include visceral symptoms, neurologic symptoms and psychiatric...

Cite
Ong LT. Psychosis symptoms associated with Niemann-Pick disease type C. Psychiatr Genet. 2021;31(4):107-118doi: 10.1097/YPG.0000000000000286.
Ong, L. T. (2021). Psychosis symptoms associated with Niemann-Pick disease type C. Psychiatric genetics, 31(4), 107-118. https://doi.org/10.1097/YPG.0000000000000286
Ong, Leong Tung. "Psychosis symptoms associated with Niemann-Pick disease type C." Psychiatric genetics vol. 31,4 (2021): 107-118. doi: https://doi.org/10.1097/YPG.0000000000000286
Ong LT. Psychosis symptoms associated with Niemann-Pick disease type C. Psychiatr Genet. 2021 Aug 01;31(4):107-118. doi: 10.1097/YPG.0000000000000286. PMID: 34133410.
Copy Download .nbib Format: NLM
Protocol for a pharmacogenetic study of antidepressants: characterization of drug-metabolizing profiles of cytochromes CYP2D6 and CYP2C19 in a Sardinian population of patients with major depressive disorder.

Psychiatric genetics

Pinna M, Manchia M, Pisanu C, Pinna F, Paribello P, Carta A, Meloni A, Conversano C, Del Zompo M, Mola F, Squassina A, Carpiniello B.
PMID: 34282075
Psychiatr Genet. 2021 Oct 01;31(5):186-193. doi: 10.1097/YPG.0000000000000293.

The effectiveness of antidepressants shows high interindividual variability ranging from full symptomatologic remission to treatment-resistant depression. Many factors can determine the variation in the clinical response, but a fundamental role is played by genetic variation within the genes encoding...

Cite
Pinna M, Manchia M, Pisanu C, et al. Protocol for a pharmacogenetic study of antidepressants: characterization of drug-metabolizing profiles of cytochromes CYP2D6 and CYP2C19 in a Sardinian population of patients with major depressive disorder. Psychiatr Genet. 2021;31(5):186-193doi: 10.1097/YPG.0000000000000293.
Pinna, M., Manchia, M., Pisanu, C., Pinna, F., Paribello, P., Carta, A., Meloni, A., Conversano, C., Del Zompo, M., Mola, F., Squassina, A., & Carpiniello, B. (2021). Protocol for a pharmacogenetic study of antidepressants: characterization of drug-metabolizing profiles of cytochromes CYP2D6 and CYP2C19 in a Sardinian population of patients with major depressive disorder. Psychiatric genetics, 31(5), 186-193. https://doi.org/10.1097/YPG.0000000000000293
Pinna, Marco, et al. "Protocol for a pharmacogenetic study of antidepressants: characterization of drug-metabolizing profiles of cytochromes CYP2D6 and CYP2C19 in a Sardinian population of patients with major depressive disorder." Psychiatric genetics vol. 31,5 (2021): 186-193. doi: https://doi.org/10.1097/YPG.0000000000000293
Pinna M, Manchia M, Pisanu C, Pinna F, Paribello P, Carta A, Meloni A, Conversano C, Del Zompo M, Mola F, Squassina A, Carpiniello B. Protocol for a pharmacogenetic study of antidepressants: characterization of drug-metabolizing profiles of cytochromes CYP2D6 and CYP2C19 in a Sardinian population of patients with major depressive disorder. Psychiatr Genet. 2021 Oct 01;31(5):186-193. doi: 10.1097/YPG.0000000000000293. PMID: 34282075.
Copy Download .nbib Format: NLM
Explore the role of CR1 genetic variants in late-onset Alzheimer's disease susceptibility.

Psychiatric genetics

Lu L, Yao QY, Ruan SS, Hu JW, Long WJ, Dai WZ, Ma T, Zhu XC.
PMID: 34347684
Psychiatr Genet. 2021 Dec 01;31(6):216-229. doi: 10.1097/YPG.0000000000000291.

BACKGROUND: Complement component (3b/4b) receptor 1 (CR1) is an interesting candidate gene which has a close connection with Alzheimer's disease, and its polymorphisms have been reported to link to the late-onset Alzheimer's disease (LOAD) susceptibility. However, the findings of...

Cite
Lu L, Yao QY, Ruan SS, et al. Explore the role of CR1 genetic variants in late-onset Alzheimer's disease susceptibility. Psychiatr Genet. 2021;31(6):216-229doi: 10.1097/YPG.0000000000000291.
Lu, L., Yao, Q. Y., Ruan, S. S., Hu, J. W., Long, W. J., Dai, W. Z., Ma, T., & Zhu, X. C. (2021). Explore the role of CR1 genetic variants in late-onset Alzheimer's disease susceptibility. Psychiatric genetics, 31(6), 216-229. https://doi.org/10.1097/YPG.0000000000000291
Lu, Liu, et al. "Explore the role of CR1 genetic variants in late-onset Alzheimer's disease susceptibility." Psychiatric genetics vol. 31,6 (2021): 216-229. doi: https://doi.org/10.1097/YPG.0000000000000291
Lu L, Yao QY, Ruan SS, Hu JW, Long WJ, Dai WZ, Ma T, Zhu XC. Explore the role of CR1 genetic variants in late-onset Alzheimer's disease susceptibility. Psychiatr Genet. 2021 Dec 01;31(6):216-229. doi: 10.1097/YPG.0000000000000291. PMID: 34347684.
Copy Download .nbib Format: NLM
Telomere length and telomerase activity of leukocytes as biomarkers of selective serotonin reuptake inhibitor responses in patients with major depressive disorder.

Psychiatric genetics

da Silva RS, de Moraes LS, da Rocha CAM, Ferreira-Fernandes H, Yoshioka FKN, Rey JA, Pinto GR, Burbano RR.
PMID: 34873130
Psychiatr Genet. 2021 Dec 06; doi: 10.1097/YPG.0000000000000305. Epub 2021 Dec 06.

We analyze the leukocyte telomere length (LTL) and telomerase activity in patients with major depressive disorder (MDD) before and after treatment with selective serotonin reuptake inhibitors (SSRIs). Before treatment, there was a reduction in the LTLs and expression levels...

Cite
da Silva RS, de Moraes LS, da Rocha CAM, et al. Telomere length and telomerase activity of leukocytes as biomarkers of selective serotonin reuptake inhibitor responses in patients with major depressive disorder. Psychiatr Genet. 2021;doi: 10.1097/YPG.0000000000000305.
da Silva, R. S., de Moraes, L. S., da Rocha, C. A. M., Ferreira-Fernandes, H., Yoshioka, F. K. N., Rey, J. A., Pinto, G. R., & Burbano, R. R. (2021). Telomere length and telomerase activity of leukocytes as biomarkers of selective serotonin reuptake inhibitor responses in patients with major depressive disorder. Psychiatric genetics, . https://doi.org/10.1097/YPG.0000000000000305
da Silva, Raiany S, et al. "Telomere length and telomerase activity of leukocytes as biomarkers of selective serotonin reuptake inhibitor responses in patients with major depressive disorder." Psychiatric genetics vol. (2021). doi: https://doi.org/10.1097/YPG.0000000000000305
da Silva RS, de Moraes LS, da Rocha CAM, Ferreira-Fernandes H, Yoshioka FKN, Rey JA, Pinto GR, Burbano RR. Telomere length and telomerase activity of leukocytes as biomarkers of selective serotonin reuptake inhibitor responses in patients with major depressive disorder. Psychiatr Genet. 2021 Dec 06; doi: 10.1097/YPG.0000000000000305. Epub 2021 Dec 06. PMID: 34873130.
Copy Download .nbib Format: NLM
Showing 49 to 59 of 59 entries